Middle East & Africa Clinical Trials Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)

No. of Pages: 128    |    Report Code: BMIRE00029011    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Clinical Trials Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East & Africa Clinical Trials Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East & Africa Clinical Trials Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Practice of Outsourcing Clinical Studies with Massive Rise in Number of Trials
5.2 Market Opportunities
  • 5.2.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.3 Future Trends
  • 5.3.1 AI-driven Clinical Trials
5.4 Impact of Drivers and Restraints

6. Middle East & Africa Clinical Trials Market Regional Analysis

6.1 Middle East & Africa Clinical Trials Market Overview
6.2 Middle East & Africa Clinical Trials Market Revenue 2020-2028 (US$ Million)
6.3 Middle East & Africa Clinical Trials Market Forecast Analysis

7. Middle East & Africa Clinical Trials Market Analysis – by Study Design

7.1 Interventional
  • 7.1.1 Overview
  • 7.1.2 Interventional: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Observational
  • 7.2.1 Overview
  • 7.2.2 Observational: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Expanded Access
  • 7.3.1 Overview
  • 7.3.2 Expanded Access: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Clinical Trials Market Analysis – by Phase

8.1 Phase I
  • 8.1.1 Overview
  • 8.1.2 Phase I: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Phase II
  • 8.2.1 Overview
  • 8.2.2 Phase II: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Phase III
  • 8.3.1 Overview
  • 8.3.2 Phase III: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Phase IV
  • 8.4.1 Overview
  • 8.4.2 Phase IV: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Clinical Trials Market Analysis – by Indication

9.1 Autoimmune/Inflammation
  • 9.1.1 Overview
  • 9.1.2 Phase IV: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Pain Management
  • 9.2.1 Overview
  • 9.2.2 Phase IV: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Oncology
  • 9.3.1 Overview
  • 9.3.2 Phase IV: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.4 CNS Condition
  • 9.4.1 Overview
  • 9.4.2 Phase IV: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Diabetes
  • 9.5.1 Overview
  • 9.5.2 Phase IV: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Obesity
  • 9.6.1 Overview
  • 9.6.2 Phase IV: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Cardiovascular
  • 9.7.1 Overview
  • 9.7.2 Phase IV: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Clinical Trials Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East & Africa Clinical Trials Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Middle East & Africa Clinical Trials Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East & Africa Clinical Trials Market Breakdown, by Study Design
    • 10.1.1.1.2 South Africa: Middle East & Africa Clinical Trials Market Breakdown, by Phase
    • 10.1.1.1.3 South Africa: Middle East & Africa Clinical Trials Market Breakdown, by Indication
  • 10.1.1.2 Saudi Arabia: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East & Africa Clinical Trials Market Breakdown, by Study Design
    • 10.1.1.2.2 Saudi Arabia: Middle East & Africa Clinical Trials Market Breakdown, by Phase
    • 10.1.1.2.3 Saudi Arabia: Middle East & Africa Clinical Trials Market Breakdown, by Indication
  • 10.1.1.3 UAE: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East & Africa Clinical Trials Market Breakdown, by Study Design
    • 10.1.1.3.2 UAE: Middle East & Africa Clinical Trials Market Breakdown, by Phase
    • 10.1.1.3.3 UAE: Middle East & Africa Clinical Trials Market Breakdown, by Indication
  • 10.1.1.4 Rest of Middle East and Africa: Middle East & Africa Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa Clinical Trials Market Breakdown, by Study Design
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Clinical Trials Market Breakdown, by Phase
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East & Africa Clinical Trials Market Breakdown, by Indication

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East & Africa Clinical Trials Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 ICON Plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 IQVIA Holdings Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Laboratory Corp of America Holdings
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Parexel International Corp
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 SGS SA
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Syneos Health Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Thermo Fisher Scientific Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 WuXi AppTec Co Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Middle East & Africa Clinical Trials Market

  1. ICON Plc
  2. IQVIA Holdings Inc
  3. Laboratory Corp of America Holdings
  4. Parexel International Corp
  5. SGS SA
  6. Syneos Health Inc
  7. Thermo Fisher Scientific Inc
  8. WuXi AppTec Co Ltd
middle-east-and-africa-clinical-trials-market